Characterization of SARS-CoV-2 vaccine waning in Mexico
View ORCID ProfileCarlos Hernandez-Suarez, View ORCID ProfileEfren Murillo-Zamora
doi: https://doi.org/10.1101/2022.04.17.22273854
Carlos Hernandez-Suarez
aInstituto de Ciencias Tecnología e Innovación, Universidad Francisco Gavidia, El Progreso St., No. 2748, Colonia Flor Blanca, San Salvador, El Salvador
Efren Murillo-Zamora
bDepartamento de Epidemiología, Unidad de Medicina Familiar No. 19, IMSS, Av. Javier Mina 301, 28000, Colima, Colima. MEXICO

Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted April 18, 2022.
Characterization of SARS-CoV-2 vaccine waning in Mexico
Carlos Hernandez-Suarez, Efren Murillo-Zamora
medRxiv 2022.04.17.22273854; doi: https://doi.org/10.1101/2022.04.17.22273854
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)